IMGN logo

ImmunoGen (IMGN) Cash From Investing

Annual CFI

-$1.36 M
+$70.00 K+4.88%

December 31, 2022

Summary

Performance

1-Year Change

+4.88%

3-Year Change

-155.91%

5-Year Change

-22.22%

15-Year Change

-22.22%

IMGN Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$26.85 M
IMGN annual cash flow from investing activities is currently -105.08% below its historical high of $26.85 million

3-Year Low

-$1.43 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
IMGN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
IMGN next annual earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Annual CFF

$27.55 M
IMGN annual cash flow from financing activities is $27.55 million

Annual CFO

-$229.80 M
IMGN annual cash flow from operations is -$229.80 million

Annual FCF

-$231.17 M
IMGN annual free cash flow is -$231.17 million

Annual CAPEX

$1.36 M
IMGN annual capital expenditures is $1.36 million

Quarterly CFI

-$1.35 M
-$1.28 M-1635.90%

September 30, 2023

Summary

Performance

3-Month Change

-1635.9%

1-Year Change

-124.92%

3-Year Change

-75.62%

5-Year Change

+35.31%

IMGN Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$21.34 M
IMGN quarterly cash flow from investing activities is currently -106.34% below its historical high of $21.34 million

3-Year Low

-$1.35 M
IMGN quarterly cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

Quarterly CFF

$32.13 M
IMGN quarterly cash flow from financing activities is $32.13 million

Quarterly CFO

$2.77 M
IMGN quarterly cash flow from operations is $2.77 million

Quarterly FCF

$1.42 M
IMGN quarterly free cash flow is $1.42 million

Quarterly CAPEX

$1.35 M
IMGN quarterly capital expenditures is $1.35 million

TTM CFI

-$1.89 M
-$752.00 K-66.14%

September 30, 2023

Summary

Performance

3-Month Change

-66.14%

1-Year Change

-27.21%

3-Year Change

-166.51%

5-Year Change

-254.41%

IMGN TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$34.77 M
IMGN TTM cash flow from investing activities is currently -105.43% below its historical high of $34.77 million

3-Year Low

-$1.89 M
IMGN TTM cash flow from investing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
IMGN previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
IMGN next earnings announcement has not yet been scheduled

OtherIMGNcash flowmetrics:

TTM CFF

$495.80 M
IMGN TTM cash flow from financing activities is $495.80 million

TTM CFO

-$197.89 M
IMGN TTM cash flow from operations is -$197.89 million

TTM FCF

-$199.78 M
IMGN TTM free cash flow is -$199.78 million

TTM CAPEX

$1.89 M
IMGN TTM capital expenditures is $1.89 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

IMGN Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.9%-124.9%-27.2%
3 y3 years-155.9%-75.6%-166.5%
5 y5 years-22.2%+35.3%-254.4%

IMGN Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+5.1%+1635.9%at low+122.8%at low
5 y5-year-368.0%+5.1%-160.7%at low-159.0%at low
alltimeall time-105.1%+8862.0%-106.3%+9622.1%-105.4%+7280.3%

ImmunoGen Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2023
-
-$1.35 M(+1635.9%)
-$1.89 M(+66.1%)
Jun 2023
-
-$78.00 K(-62.7%)
-$1.14 M(-10.2%)
Mar 2023
-
-$209.00 K(-15.7%)
-$1.27 M(-7.2%)
Dec 2022
-$1.36 M(-4.9%)
-$248.00 K(-58.8%)
-$1.36 M(-8.1%)
Sep 2022
-
-$602.00 K(+190.8%)
-$1.49 M(+47.3%)
Jun 2022
-
-$207.00 K(-32.6%)
-$1.01 M(+18.9%)
Mar 2022
-
-$307.00 K(-16.8%)
-$848.00 K(-40.9%)
Dec 2021
-$1.43 M(-381.7%)
-$369.00 K(+195.2%)
-$1.43 M(+22.9%)
Sep 2021
-
-$125.00 K(+166.0%)
-$1.17 M(-35.6%)
Jun 2021
-
-$47.00 K(-94.7%)
-$1.81 M(+1.3%)
Mar 2021
-
-$893.00 K(+775.5%)
-$1.79 M(-451.5%)
Dec 2020
$509.00 K(-195.5%)
-$102.00 K(-86.8%)
$509.00 K(-82.1%)
Sep 2020
-
-$771.00 K(+3252.2%)
$2.84 M(-11.4%)
Jun 2020
-
-$23.00 K(-101.6%)
$3.20 M(+6.8%)
Mar 2020
-
$1.41 M(-37.0%)
$3.00 M(-662.7%)
Dec 2019
-$533.00 K(-89.8%)
$2.23 M(-647.7%)
-$533.00 K(-85.9%)
Sep 2019
-
-$407.00 K(+78.5%)
-$3.79 M(-30.8%)
Jun 2019
-
-$228.00 K(-89.3%)
-$5.47 M(-13.7%)
Mar 2019
-
-$2.13 M(+107.3%)
-$6.34 M(+20.9%)
Dec 2018
-$5.25 M(+370.1%)
-$1.03 M(-51.0%)
-$5.25 M(+16.9%)
Sep 2018
-
-$2.09 M(+90.4%)
-$4.49 M(+82.2%)
Jun 2018
-
-$1.10 M(+6.9%)
-$2.46 M(+44.3%)
Mar 2018
-
-$1.03 M(+282.2%)
-$1.71 M(+53.0%)
Dec 2017
-$1.12 M(-20.6%)
-$269.00 K(+295.6%)
-$1.12 M(+31.8%)
Sep 2017
-
-$68.00 K(-80.1%)
-$847.00 K(-56.8%)
Jun 2017
-
-$342.00 K(-21.7%)
-$1.96 M(-42.1%)
Mar 2017
-
-$437.00 K(-63.0%)
-$3.39 M(-58.6%)
Dec 2016
-$1.41 M(-86.4%)
-
-
Sep 2016
-
-$1.18 M(-33.2%)
-$8.18 M(-21.2%)
Jun 2016
-$10.38 M(+39.7%)
-$1.77 M(-49.1%)
-$10.38 M(-5.7%)
Mar 2016
-
-$3.48 M(+98.8%)
-$11.00 M(+10.4%)
Dec 2015
-
-$1.75 M(-48.2%)
-$9.96 M(+9.5%)
Sep 2015
-
-$3.38 M(+40.9%)
-$9.09 M(+22.5%)
Jun 2015
-$7.42 M(-9.3%)
-$2.40 M(-1.7%)
-$7.42 M(-12.7%)
Mar 2015
-
-$2.44 M(+176.4%)
-$8.50 M(+0.3%)
Dec 2014
-
-$882.00 K(-48.4%)
-$8.48 M(-9.1%)
Sep 2014
-
-$1.71 M(-50.8%)
-$9.32 M(+13.9%)
Jun 2014
-$8.19 M(+121.5%)
-$3.47 M(+43.9%)
-$8.19 M(+35.3%)
Mar 2014
-
-$2.41 M(+39.9%)
-$6.05 M(+53.4%)
Dec 2013
-
-$1.73 M(+201.7%)
-$3.94 M(+21.1%)
Sep 2013
-
-$572.00 K(-57.3%)
-$3.26 M(-11.9%)
Jun 2013
-$3.70 M(+24.5%)
-$1.34 M(+336.2%)
-$3.70 M(+6.0%)
Mar 2013
-
-$307.00 K(-70.4%)
-$3.49 M(-15.5%)
Dec 2012
-
-$1.04 M(+2.6%)
-$4.13 M(+21.8%)
Sep 2012
-
-$1.01 M(-10.4%)
-$3.39 M(+14.2%)
Jun 2012
-$2.97 M(+349.7%)
-$1.13 M(+19.2%)
-$2.97 M(+29.1%)
Mar 2012
-
-$948.00 K(+218.1%)
-$2.30 M(+14.2%)
Dec 2011
-
-$298.00 K(-49.7%)
-$2.01 M(-8.5%)
Sep 2011
-
-$592.00 K(+28.4%)
-$2.20 M(+233.5%)
Jun 2011
-$660.00 K(-25.2%)
-$461.00 K(-30.4%)
-$660.00 K(+4.3%)
Mar 2011
-
-$662.00 K(+36.2%)
-$633.00 K(+375.9%)
Dec 2010
-
-$486.00 K(-151.2%)
-$133.00 K(-181.6%)
Sep 2010
-
$949.00 K(-318.7%)
$163.00 K(-118.5%)
Jun 2010
-$882.00 K(-107.4%)
-$434.00 K(+167.9%)
-$882.00 K(-120.8%)
Mar 2010
-
-$162.00 K(-14.7%)
$4.24 M(-26.8%)
Dec 2009
-
-$190.00 K(+97.9%)
$5.79 M(-40.8%)
Sep 2009
-
-$96.00 K(-102.0%)
$9.78 M(-18.5%)
Jun 2009
$11.99 M(-20.8%)
$4.69 M(+237.3%)
$11.99 M(-25.2%)
Mar 2009
-
$1.39 M(-63.4%)
$16.05 M(+19.7%)
Dec 2008
-
$3.80 M(+79.3%)
$13.40 M(-429.2%)
Sep 2008
-
$2.12 M(-75.8%)
-$4.07 M(-126.9%)
Jun 2008
$15.15 M(-22.0%)
$8.74 M(-796.3%)
$15.15 M(+12.7%)
Mar 2008
-
-$1.25 M(-90.8%)
$13.45 M(-29.4%)
Dec 2007
-
-$13.67 M(-164.1%)
$19.05 M(-45.2%)
Sep 2007
-
$21.34 M(+203.6%)
$34.77 M(+79.0%)
Jun 2007
$19.42 M
$7.03 M(+61.6%)
$19.42 M(-4.3%)
DateAnnualQuarterlyTTM
Mar 2007
-
$4.35 M(+112.6%)
$20.30 M(+36.0%)
Dec 2006
-
$2.05 M(-65.9%)
$14.92 M(-18.1%)
Sep 2006
-
$6.00 M(-24.2%)
$18.22 M(+25.5%)
Jun 2006
$14.52 M(-902.7%)
$7.90 M(-871.1%)
$14.52 M(+410.9%)
Mar 2006
-
-$1.02 M(-119.2%)
$2.84 M(-50.3%)
Dec 2005
-
$5.35 M(+133.4%)
$5.72 M(+381.2%)
Sep 2005
-
$2.29 M(-160.7%)
$1.19 M(-165.7%)
Jun 2005
-$1.81 M(-271.8%)
-$3.77 M(-303.5%)
-$1.81 M(-59.9%)
Mar 2005
-
$1.85 M(+127.1%)
-$4.51 M(-280.2%)
Dec 2004
-
$817.00 K(-215.7%)
$2.50 M(-78.3%)
Sep 2004
-
-$706.00 K(-89.1%)
$11.52 M(+993.8%)
Jun 2004
$1.05 M(-96.1%)
-$6.47 M(-173.0%)
$1.05 M(-94.2%)
Mar 2004
-
$8.86 M(-9.9%)
$18.27 M(-1.0%)
Dec 2003
-
$9.83 M(-188.0%)
$18.46 M(+122.0%)
Sep 2003
-
-$11.17 M(-204.0%)
$8.31 M(-69.0%)
Jun 2003
$26.85 M(+136.7%)
$10.74 M(+18.6%)
$26.85 M(+52.8%)
Mar 2003
-
$9.06 M(-2996.9%)
$17.57 M(-11.0%)
Dec 2002
-
-$312.60 K(-104.2%)
$19.75 M(+9.1%)
Sep 2002
-
$7.37 M(+402.6%)
$18.10 M(+59.6%)
Jun 2002
$11.34 M(-109.3%)
$1.47 M(-86.9%)
$11.34 M(-10.5%)
Mar 2002
-
$11.23 M(-672.5%)
$12.67 M(+218.9%)
Dec 2001
-
-$1.96 M(-421.1%)
$3.97 M(-103.2%)
Sep 2001
-
$610.80 K(-78.1%)
-$125.70 M(+2.8%)
Jun 2001
-$122.24 M(+680.4%)
$2.79 M(+10.4%)
-$122.24 M(-5.8%)
Mar 2001
-
$2.53 M(-101.9%)
-$129.83 M(-6.9%)
Dec 2000
-
-$131.64 M(-3331.9%)
-$139.41 M(+1082.4%)
Sep 2000
-
$4.07 M(-185.0%)
-$11.79 M(-24.7%)
Jun 2000
-$15.66 M(-2058.0%)
-$4.79 M(-32.0%)
-$15.66 M(+46.8%)
Mar 2000
-
-$7.05 M(+75.7%)
-$10.67 M(+221.9%)
Dec 1999
-
-$4.02 M(-2107.6%)
-$3.32 M(-431.5%)
Sep 1999
-
$200.00 K(0.0%)
$1.00 M(+25.0%)
Jun 1999
$800.00 K(+166.7%)
$200.00 K(-33.3%)
$800.00 K(+60.0%)
Mar 1999
-
$300.00 K(0.0%)
$500.00 K(-16.7%)
Dec 1998
-
$300.00 K(>+9900.0%)
$600.00 K(+100.0%)
Sep 1998
-
$0.00(-100.0%)
$300.00 K(0.0%)
Jun 1998
$300.00 K(>+9900.0%)
-$100.00 K(-125.0%)
$300.00 K(-25.0%)
Mar 1998
-
$400.00 K(>+9900.0%)
$400.00 K(>+9900.0%)
Dec 1997
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1997
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1997
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 1997
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1996
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1996
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1996
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Mar 1996
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1995
-
$0.00(0.0%)
$0.00(0.0%)
Sep 1995
-
$0.00(-100.0%)
$0.00(-100.0%)
Jun 1995
$19.10 M(-930.4%)
-
-
Sep 1994
-
$4.90 M(+226.7%)
-$300.00 K(-87.0%)
Jun 1994
-$2.30 M(-83.5%)
$1.50 M(-120.8%)
-$2.30 M(+187.5%)
Mar 1994
-
-$7.20 M(-1540.0%)
-$800.00 K(-72.4%)
Dec 1993
-
$500.00 K(-82.8%)
-$2.90 M(-85.2%)
Sep 1993
-
$2.90 M(-3.3%)
-$19.60 M(+41.0%)
Jun 1993
-$13.90 M(-534.4%)
$3.00 M(-132.3%)
-$13.90 M(-17.8%)
Mar 1993
-
-$9.30 M(-42.6%)
-$16.90 M(+122.4%)
Dec 1992
-
-$16.20 M(-288.4%)
-$7.60 M(-188.4%)
Sep 1992
-
$8.60 M(-9.5%)
$8.60 M(-165.2%)
Jun 1992
$3.20 M(-113.9%)
-
-
Sep 1991
-
$9.50 M(-142.6%)
-$13.20 M(-42.6%)
Jun 1991
-$23.00 M(+351.0%)
-$22.30 M(>+9900.0%)
-$23.00 M(+3185.7%)
Mar 1991
-
-$100.00 K(-66.7%)
-$700.00 K(+16.7%)
Dec 1990
-
-$300.00 K(0.0%)
-$600.00 K(+100.0%)
Sep 1990
-
-$300.00 K(+200.0%)
-$300.00 K(+200.0%)
Jun 1990
-$5.10 M(+628.6%)
-
-
Sep 1989
-
-$100.00 K
-$100.00 K
Jun 1989
-$700.00 K
-
-

FAQ

  • What is ImmunoGen annual cash flow from investing activities?
  • What is the all time high annual CFI for ImmunoGen?
  • What is ImmunoGen annual CFI year-on-year change?
  • What is ImmunoGen quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for ImmunoGen?
  • What is ImmunoGen quarterly CFI year-on-year change?
  • What is ImmunoGen TTM cash flow from investing activities?
  • What is the all time high TTM CFI for ImmunoGen?
  • What is ImmunoGen TTM CFI year-on-year change?

What is ImmunoGen annual cash flow from investing activities?

The current annual CFI of IMGN is -$1.36 M

What is the all time high annual CFI for ImmunoGen?

ImmunoGen all-time high annual cash flow from investing activities is $26.85 M

What is ImmunoGen annual CFI year-on-year change?

Over the past year, IMGN annual cash flow from investing activities has changed by +$70.00 K (+4.88%)

What is ImmunoGen quarterly cash flow from investing activities?

The current quarterly CFI of IMGN is -$1.35 M

What is the all time high quarterly CFI for ImmunoGen?

ImmunoGen all-time high quarterly cash flow from investing activities is $21.34 M

What is ImmunoGen quarterly CFI year-on-year change?

Over the past year, IMGN quarterly cash flow from investing activities has changed by -$752.00 K (-124.92%)

What is ImmunoGen TTM cash flow from investing activities?

The current TTM CFI of IMGN is -$1.89 M

What is the all time high TTM CFI for ImmunoGen?

ImmunoGen all-time high TTM cash flow from investing activities is $34.77 M

What is ImmunoGen TTM CFI year-on-year change?

Over the past year, IMGN TTM cash flow from investing activities has changed by -$404.00 K (-27.21%)